COMMUNIQUÉS West-GlobeNewswire

TiGenix annonce l'approbation d'un nom commercial en Europe pour son produit candidat en phase de développement, le Cx601
16/11/2017
COMMUNIQUÉ DE PRESSE TiGenix annonce l'approbation d'un nom commercial en Europe pour son produit candidat en phase de développement, le Cx601 Darvadstrocel est la dénomination commune internationale (DCI) approuvée [...]
Orphazyme announces the result of its IPO, including an offer price of DKK 80 per share
16/11/2017
Company announcement Orphazyme A/S No. 5/2017 Ole Maaløes Vej 3 DK-2200 Copenhagen N www.orphazyme.com Company Registration No. 32266355 16 November 2017 NOT FOR RELEASE OR DISTRIBUTION OR PUBLICATION IN WHOLE OR IN [...]
Orphazyme A/S: Election of new members of the Board of Directors
16/11/2017
Company announcement Orphazyme A/S No. 4/2017 Ole Maaløes Vej 3 DK-2200 Copenhagen N www.orphazyme.com Company Registration No. 32266355 16 November 2017 On 16 November 2017, Orphazyme A/S ("Orphazyme") held an [...]
Arsanis Announces Pricing of Initial Public Offering
16/11/2017
WALTHAM, Mass. and VIENNA, Austria, Nov. 15, 2017 (GLOBE NEWSWIRE) -- Arsanis, Inc., a clinical-stage biopharmaceutical company focused on applying monoclonal antibody immunotherapies to address serious infectious [...]
Achillion Announces Pricing of Secondary Offering Of Common Stock
16/11/2017
NEW HAVEN, Conn., Nov. 15, 2017 (GLOBE NEWSWIRE) -- Achillion Pharmaceuticals, Inc. (“Achillion”) (NASDAQ: ACHN ) today announced the pricing of an underwritten public offering of 18,367,346 shares of its common stock [...]
Loop Industries provides update on the Montreal facility
15/11/2017
MONTREAL, Nov. 15, 2017 (GLOBE NEWSWIRE) -- Loop Industries, Inc. (OTCQX:LLPP), a leader in sustainably produced polyethylene terephthalate (Polyester/PET) resin, announced today that following its due diligence review [...]
AxoGen, Inc. Announces Proposed Public Offering of Common Stock
15/11/2017
ALACHUA, Fla., Nov. 15, 2017 (GLOBE NEWSWIRE) -- AxoGen, Inc. (NASDAQ: AXGN ), a global leader in developing and marketing innovative surgical solutions for the repair of peripheral nerve damage, announced today that it [...]
EDAP TMS Reports Third Quarter 2017 Results
15/11/2017
EDAP TMS Reports Third Quarter 2017 Results EDAP's HIFU patient treatment revenues grew 29% compared to third quarter 2016. EDAP received FDA clearance for its Ablatherm Fusion ® late in the quarter. EDAP's cash [...]
MacroGenics Names Dr. Jay Siegel to its Board of Directors
15/11/2017
ROCKVILLE, MD, Nov. 15, 2017 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (NASDAQ: MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for [...]
Allscripts to deliver anaesthesiology solution at the Royal Adelaide Hospital
15/11/2017
ADELAIDE, Australia, Nov. 15, 2017 (GLOBE NEWSWIRE) -- Allscripts (NASDAQ: MDRX ) has been appointed by South Australia Health to deliver its anaesthesia information management system (AIMS) at the Royal Adelaide [...]
Allscripts to deliver anesthesiology solution at the Royal Adelaide Hospital
15/11/2017
ADELAIDE, Australia, Nov. 15, 2017 (GLOBE NEWSWIRE) -- Allscripts (NASDAQ: MDRX ) has been appointed by South Australia Health to deliver its anesthesia information management system (AIMS) at the Royal Adelaide [...]
Spring Bank Pharmaceuticals Announces Positive Top-Line Results from the Second Cohort of Part A of the Phase 2 ACHIEVE Trial
15/11/2017
Low Dose of Inarigivir Soproxil (50mg) Monotherapy Demonstrates a Favorable Safety Profile and Significant Dose-Dependent Antiviral Activity, Meeting Both Primary Endpoints Conference Call Scheduled for Tomorrow, Nov. [...]
K2M Group Holdings, Inc. to Participate in the 29th Annual Piper Jaffray Healthcare Conference
15/11/2017
LEESBURG, Va., Nov. 15, 2017 (GLOBE NEWSWIRE) -- K2M Group Holdings, Inc. (NASDAQ: KTWO ) (the "Company" or "K2M"), a global leader of complex spine and minimally invasive solutions focused on achieving three- [...]
BioCanCell Announces Updated Results from the Phase 2 Clinical Trial of BC-819 and BCG in Patients with Bladder Cancer
15/11/2017
JERUSALEM, Nov. 15, 2017 (GLOBE NEWSWIRE) -- BioCanCell Ltd. (TASE: BICL ), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel therapies to treat cancer, [...]
Adverum Biotechnologies to Present at Upcoming Conferences
15/11/2017
MENLO PARK, Calif., Nov. 15, 2017 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (Nasdaq: ADVM ), a leading gene therapy company targeting unmet medical needs in serious rare and ocular diseases, announced today that [...]
Nuvectra to Present at the 29th Annual Piper Jaffray Healthcare Conference
15/11/2017
PLANO, Texas, Nov. 15, 2017 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ: NVTR ), a neurostimulation medical device company, announced today that Scott Drees, Chief Executive Officer, and Walter Berger, Chief [...]
Articles of Association for Genmab A/S
15/11/2017
Genmab A/S has published its Articles of Association dated November 14, 2017. The Articles of Association can be found on Genmab’s website: http://ir.genmab.com/releases.cfm Contact: Rachel Curtis Gravesen, Senior Vice [...]
Safe Landing, Teen Substance Abuse Treatment Center, Opens in North Miami
15/11/2017
NORTH MIAMI, Fla., Nov. 15, 2017 (GLOBE NEWSWIRE) -- The substance abuse epidemic impacting all of the United States is devastating families, derailing promising futures, and threatening American communities. One of the [...]
Ultragenyx Announces FDA Approval of MEPSEVII™ (vestronidase alfa), the First Therapy for Progressive and Debilitating Rare Genetic Disease Mucopolysaccharidosis VII
15/11/2017
NOVATO, Calif., Nov. 15, 2017 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE ), a biopharmaceutical company focused on the development of novel products for rare and ultra-rare diseases, today [...]

Pages